NCT00531544View on ClinicalTrials.gov

A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248

NACompletedINTERVENTIONAL

Enrollment

350

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions

Metastatic Renal Cell Carcinoma

Interventions

DRUG

SU011248

SU011248 Expanded Access Protocol for Systemic Therapy

Trial Locations (1)

1211

KFSH&RC, Riyadh

All Listed Sponsors

lead

King Faisal Specialist Hospital & Research Center

OTHER

NCT00531544 - A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248 | Biotech Hunter | Biotech Hunter